- USD1086441design2025Intranasal Drug Delivery Device0 cites
- US12364698utility2025Compositions Containing Ibrutinib0 cites
- US12358917utility2025Processes and Intermediates for Preparing a Btk Inhibitor0 cites
- US12350266utility2025FGFR2 Inhibitors for the Treatment of Cholangiocarcinoma0 cites
- US12338243utility2025P2X7 Modulators0 cites
- US12286429utility20255-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide Derivatives Useful as a Factor Xia Inhibitors0 cites
- US12274711utility2025Method of Determining Acute Myeloid Leukemia Response to Treatment with Farnesyltransferase Inhibitors0 cites
- US12275723utility2025Compounds and Uses Thereof0 cites
- US12277929utility2025System and Method for Detecting Cognitive Decline Using Speech Analysis0 cites
- US12268687utility2025Compounds and Uses Thereof0 cites
- US12251424utility2025Methods of Protecting Vascular Integrity Induced by Targeted Radiation Therapy0 cites
- US12247027utility2025P2X7 Modulators0 cites
- US12234200utility2025Synthetic Methods of Preparing Esketamine0 cites
- US12234280utility2025Anti-phf-tau Antibodies and Uses Thereof0 cites
- US12227771utility2025Expression Systems and Methods of Use Thereof0 cites
- US12215110utility2025Processes and Intermediates for Preparing a Btk Inhibitor0 cites
- US12215111utility2025Imidazopyridazine IL-17 Inhibitor Compounds0 cites
- US12208100utility2025Dosing Regimens Associated with Extended Release Paliperidone Injectable Formulations0 cites
- US12201634utility2025Methods of Treating Depression Using Orexin-2 Receptor Antagonists0 cites